Edward Thomas Ryan
#71,596
Most Influential Person Now
American bacteriologist and epidemiologist
Edward Thomas Ryan's AcademicInfluence.com Rankings
Edward Thomas Ryanmedical Degrees
Medical
#1497
World Rank
#1841
Historical Rank
#392
USA Rank
Epidemiology
#669
World Rank
#695
Historical Rank
#88
USA Rank
Edward Thomas Ryanbiology Degrees
Biology
#6298
World Rank
#8982
Historical Rank
#2043
USA Rank
Microbiology
#879
World Rank
#968
Historical Rank
#153
USA Rank
Download Badge
Medical Biology
Edward Thomas Ryan's Degrees
- Bachelors Biology Stanford University
- Doctorate Medicine Harvard University
Similar Degrees You Can Earn
Why Is Edward Thomas Ryan Influential?
(Suggest an Edit or Addition)According to Wikipedia, Edward Thomas Ryan is an American microbiologist, immunologist, and physician at Harvard University and Massachusetts General Hospital. Ryan served as president of the American Society of Tropical Medicine and Hygiene from 2009 to 2010. Ryan is Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health, Professor of Medicine at Harvard Medical School, and Director of Global Infectious Diseases at the Massachusetts General Hospital. Ryan's research and clinical focus has been on infectious diseases associated with residing in, immigrating from, or traveling through resource-limited areas. Ryan is a Fellow of the American Society of Microbiology, the American Society of Tropical Medicine and Hygiene, the American College of Physicians, and the Infectious Diseases Society of America.
Edward Thomas Ryan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- SARS-CoV-2 viral load is associated with increased disease severity and mortality (2020) (576)
- Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients (2020) (496)
- Distinct Early Serological Signatures Track with SARS-CoV-2 Survival (2020) (303)
- Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016 (2018) (302)
- Test performance evaluation of SARS-CoV-2 serological assays (2020) (266)
- Environmental enteric dysfunction: pathogenesis, diagnosis, and clinical consequences. (2014) (217)
- Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events (2020) (215)
- Susceptibility to Vibrio cholerae Infection in a Cohort of Household Contacts of Patients with Cholera in Bangladesh (2008) (214)
- Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality (2020) (210)
- Blood Group, Immunity, and Risk of Infection with Vibrio cholerae in an Area of Endemicity (2005) (197)
- Diarrheal epidemics in Dhaka, Bangladesh, during three consecutive floods: 1988, 1998, and 2004. (2005) (194)
- Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence. (2014) (192)
- Illness after international travel. (2002) (185)
- Infectious diseases of severe weather-related and flood-related natural disasters (2006) (181)
- Health advice and immunizations for travelers. (2000) (167)
- Implications of Acquired Environmental Enteric Dysfunction for Growth and Stunting in Infants and Children Living in Low- and Middle-Income Countries (2013) (161)
- Bacteremia, fever, and splenomegaly caused by a newly recognized bartonella species. (2007) (159)
- Clinical outcomes in household contacts of patients with cholera in Bangladesh. (2009) (147)
- Meeting Cholera's Challenge to Haiti and the World: A Joint Statement on Cholera Prevention and Care (2011) (142)
- Dynamics and significance of the antibody response to SARS-CoV-2 infection (2020) (138)
- Informal Urban Settlements and Cholera Risk in Dar es Salaam, Tanzania (2010) (135)
- Gut Microbial Succession Follows Acute Secretory Diarrhea in Humans (2015) (135)
- Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae (2003) (130)
- Global TravEpiNet: a national consortium of clinics providing care to international travelers--analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. (2012) (126)
- Evaluation of SARS-CoV-2 serology assays reveals a range of test performance (2020) (125)
- Antigen-Specific Memory B-Cell Responses to Vibrio cholerae O1 Infection in Bangladesh (2009) (119)
- Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh. (2008) (116)
- Diagnostics for invasive Salmonella infections: Current challenges and future directions. (2015) (116)
- Cholera vaccines. (2000) (114)
- Pre-travel health advice-seeking behavior among US international travelers departing from Boston Logan International Airport. (2010) (114)
- Humoral signatures of protective and pathological SARS-CoV-2 infection in children (2021) (110)
- Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain (1997) (109)
- Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital (2020) (109)
- Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh. (2004) (104)
- Transcriptional Profiling of Vibrio cholerae Recovered Directly from Patient Specimens during Early and Late Stages of Human Infection (2005) (100)
- Ultra-sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease (2020) (96)
- Cholera in the 21st century (2011) (94)
- Emergence of Extensively Drug-Resistant Salmonella Typhi Infections Among Travelers to or from Pakistan — United States, 2016–2018 (2019) (92)
- Antigen-Specific Immunoglobulin A Antibodies Secreted from Circulating B Cells Are an Effective Marker for Recent Local Immune Responses in Patients with Cholera: Comparison to Antibody-Secreting Cell Responses and Other Immunological Markers (2003) (90)
- Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19 (2020) (87)
- Yersinia pestis and the plague. (2003) (86)
- Species-specific bacteria identification using differential mobility spectrometry and bioinformatics pattern recognition. (2005) (86)
- Test performance evaluation of SARS-CoV-2 serological assays (2020) (80)
- Hyperinfectivity of Human-Passaged Vibrio cholerae Can Be Modeled by Growth in the Infant Mouse (2005) (79)
- Circulating Mucosal Associated Invariant T Cells Are Activated in Vibrio cholerae O1 Infection and Associated with Lipopolysaccharide Antibody Responses (2014) (79)
- Natural Selection in a Bangladeshi Population from the Cholera-Endemic Ganges River Delta (2013) (79)
- Identification of In Vivo-Induced Bacterial Protein Antigens during Human Infection with Salmonella enterica Serovar Typhi (2006) (79)
- Antigen-Specific Memory B-Cell Responses in Bangladeshi Adults after One- or Two-Dose Oral Killed Cholera Vaccination and Comparison with Responses in Patients with Naturally Acquired Cholera (2011) (78)
- Prevention of Infection in Adult Travelers After Solid Organ Transplantation (2005) (78)
- In vivo induced antigen technology (IVIAT) (2004) (77)
- What proportion of international travellers acquire a travel-related illness? A review of the literature (2017) (74)
- Immunologic Responses to Vibrio cholerae in Patients Co-Infected with Intestinal Parasites in Bangladesh (2009) (73)
- Cryptosporidiosis among Bangladeshi children with diarrhea: a prospective, matched, case-control study of clinical features, epidemiology and systemic antibody responses. (2004) (72)
- Memory B Cell Responses to Vibrio cholerae O1 Lipopolysaccharide Are Associated with Protection against Infection from Household Contacts of Patients with Cholera in Bangladesh (2012) (70)
- Comparison of Immune Responses to the O-Specific Polysaccharide and Lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi Adult Patients with Cholera (2012) (68)
- SARS-CoV-2-specific ELISA development (2020) (68)
- Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice (1997) (68)
- Etiology and Epidemiology of Diarrhea in Hospitalized Children from Low Income Country: A Matched Case-Control Study in Central African Republic (2016) (67)
- Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh. (2006) (66)
- Transcutaneous Immunization with Clostridium difficile Toxoid A Induces Systemic and Mucosal Immune Responses and Toxin A-Neutralizing Antibodies in Mice (2007) (65)
- Analysis of Salmonella enterica Serotype Paratyphi A Gene Expression in the Blood of Bacteremic Patients in Bangladesh (2010) (64)
- Live attenuated oral cholera vaccines (2006) (63)
- Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains (1997) (63)
- Pre-Travel Health Care of Immigrants Returning Home to Visit Friends and Relatives (2013) (61)
- Comparative Proteomic Analysis of the PhoP Regulon in Salmonella enterica Serovar Typhi Versus Typhimurium (2009) (60)
- Complexity of rice-water stool from patients with Vibrio cholerae plays a role in the transmission of infectious diarrhea (2007) (58)
- The Cholera Pandemic, Still with Us after Half a Century: Time to Rethink (2011) (58)
- Characterization of Anti-Salmonella enterica Serotype Typhi Antibody Responses in Bacteremic Bangladeshi Patients by an Immunoaffinity Proteomics-Based Technology (2010) (57)
- Development of a germfree mouse model of Vibrio cholerae infection (1996) (57)
- Relatedness of Vibrio cholerae O1/O139 Isolates from Patients and Their Household Contacts, Determined by Multilocus Variable-Number Tandem-Repeat Analysis (2010) (57)
- Extensively Drug-Resistant Typhoid - Are Conjugate Vaccines Arriving Just in Time? (2018) (56)
- Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain (2021) (55)
- Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh. (2000) (55)
- Simple, direct conjugation of bacterial O-SP-core antigens to proteins: development of cholera conjugate vaccines. (2011) (54)
- Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells (2016) (52)
- Comparison of the Performance of the TPTest, Tubex, Typhidot and Widal Immunodiagnostic Assays and Blood Cultures in Detecting Patients with Typhoid Fever in Bangladesh, Including Using a Bayesian Latent Class Modeling Approach (2016) (52)
- Salmonella enterica Serovar Typhi-Specific Immunoglobulin A Antibody Responses in Plasma and Antibody in Lymphocyte Supernatant Specimens in Bangladeshi Patients with Suspected Typhoid Fever (2009) (52)
- Phylogenetic analysis of SARS-CoV-2 in the Boston area highlights the role of recurrent importation and superspreading events. (2020) (51)
- The Major Subunit of the Toxin-Coregulated Pilus TcpA Induces Mucosal and Systemic Immunoglobulin A Immune Responses in Patients with Cholera Caused by Vibrio cholerae O1 and O139 (2004) (51)
- Memory T-Cell Responses to Vibrio cholerae O1 Infection (2009) (50)
- Refusal of recommended travel-related vaccines among U.S. international travellers in Global TravEpiNet (2016) (49)
- A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice (2015) (49)
- Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance. (2019) (47)
- Immunogenicity of a Killed Bivalent (O1 and O139) Whole Cell Oral Cholera Vaccine, Shanchol, in Haiti (2014) (47)
- Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. (2008) (47)
- Mucosal Immunologic Responses in Cholera Patients in Bangladesh (2011) (47)
- Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection (2018) (47)
- Comparative Proteomic Analysis Reveals Activation of Mucosal Innate Immune Signaling Pathways during Cholera (2015) (47)
- Evaluation of a Typhoid/Paratyphoid Diagnostic Assay (TPTest) Detecting Anti-Salmonella IgA in Secretions of Peripheral Blood Lymphocytes in Patients in Dhaka, Bangladesh (2013) (46)
- In Vivo Expression and Immunoadjuvancy of a Mutant of Heat-Labile Enterotoxin of Escherichia coli in Vaccine and Vector Strains of Vibrio cholerae (1999) (46)
- Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh (2020) (45)
- LPLUNC1 modulates innate immune responses to Vibrio cholerae. (2011) (44)
- Household Transmission of Vibrio cholerae in Bangladesh (2014) (44)
- Typhoid Fever in Young Children in Bangladesh: Clinical Findings, Antibiotic Susceptibility Pattern and Immune Responses (2015) (43)
- Chemoproteomic profiling of host and pathogen enzymes active in cholera (2016) (43)
- A Comparison of Clinical and Immunologic Features in Children and Older Patients Hospitalized With Severe Cholera in Bangladesh (2008) (43)
- Estimating cholera incidence with cross-sectional serology (2019) (43)
- Development of a ΔglnA Balanced Lethal Plasmid System for Expression of Heterologous Antigens by Attenuated Vaccine Vector Strains of Vibrio cholerae (2000) (42)
- In Vivo Expression of Salmonella enterica Serotype Typhi Genes in the Blood of Patients with Typhoid Fever in Bangladesh (2011) (42)
- Memory B Cell and Other Immune Responses in Children Receiving Two Doses of an Oral Killed Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh (2012) (42)
- Comparison of Memory B Cell, Antibody-Secreting Cell, and Plasma Antibody Responses in Young Children, Older Children, and Adults with Infection Caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh (2011) (40)
- High Rates of Enteric Fever Diagnosis and Lower Burden of Culture-Confirmed Disease in Peri-urban and Rural Nepal (2017) (40)
- An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates (2021) (39)
- Immune responses to cholera in children (2012) (39)
- Identification of Immunogenic Salmonella enterica Serotype Typhi Antigens Expressed in Chronic Biliary Carriers of S. Typhi in Kathmandu, Nepal (2013) (39)
- Interferon-γ and Proliferation Responses to Salmonella enterica Serotype Typhi Proteins in Patients with S. Typhi Bacteremia in Dhaka, Bangladesh (2011) (38)
- Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium (2015) (37)
- Antigen-Specific Memory T Cell Responses after Vaccination with an Oral Killed Cholera Vaccine in Bangladeshi Children and Comparison to Responses in Patients with Naturally Acquired Cholera (2012) (36)
- Vibrio cholerae O1 Infection Induces Proinflammatory CD4+ T-Cell Responses in Blood and Intestinal Mucosa of Infected Humans (2011) (36)
- Bacterial shedding in household contacts of cholera patients in Dhaka, Bangladesh. (2014) (36)
- Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity (2020) (36)
- Immune Responses to the O-Specific Polysaccharide Antigen in Children Who Received a Killed Oral Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh (2013) (35)
- Transcutaneous Immunization with Toxin-Coregulated Pilin A Induces Protective Immunity against Vibrio cholerae O1 El Tor Challenge in Mice (2006) (35)
- Vibrio cholerae genomic diversity within and between patients (2017) (34)
- Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014 (2015) (34)
- Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies. (2002) (33)
- Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh (2018) (33)
- Proteomic Analysis of Vibrio cholerae in Human Stool (2008) (32)
- A Variant in Long Palate, Lung and Nasal Epithelium Clone 1 is Associated with Cholera in a Bangladeshi Population (2009) (32)
- Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide (2014) (32)
- Antibody responses to the immunodominant Cryptosporidium gp15 antigen and gp15 polymorphisms in a case-control study of cryptosporidiosis in children in Bangladesh. (2011) (32)
- Individuals with Le(a+b−) Blood Group Have Increased Susceptibility to Symptomatic Vibrio cholerae O1 Infection (2011) (31)
- Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine (2017) (31)
- Factors Associated with Non-typhoidal Salmonella Bacteremia versus Typhoidal Salmonella Bacteremia in Patients Presenting for Care in an Urban Diarrheal Disease Hospital in Bangladesh (2015) (31)
- Immunoproteomic Analysis of Antibody in Lymphocyte Supernatant in Patients with Typhoid Fever in Bangladesh (2013) (31)
- Defining endemic cholera at three levels of spatiotemporal resolution within Bangladesh (2018) (31)
- Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera. (2014) (30)
- Antibody-Secreting Cell Responses after Vibrio cholerae O1 Infection and Oral Cholera Vaccination in Adults in Bangladesh (2013) (30)
- Cellular and Cytokine Responses to Salmonella enterica Serotype Typhi Proteins in Patients with Typhoid Fever in Bangladesh (2014) (30)
- Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh. (2012) (29)
- Application of In Vivo Induced Antigen Technology (IVIAT) to Bacillus anthracis (2008) (29)
- Development of Immunoglobulin M Memory to Both a T-Cell-Independent and a T-Cell-Dependent Antigen following Infection with Vibrio cholerae O1 in Bangladesh (2009) (28)
- Antigen-Specific Memory B-cell Responses to Enterotoxigenic Escherichia coli Infection in Bangladeshi Adults (2014) (28)
- Study of Avidity of Antigen-Specific Antibody as a Means of Understanding Development of Long-Term Immunological Memory after Vibrio cholerae O1 Infection (2012) (28)
- Genetic Diversity of Cryptosporidium spp. from Bangladeshi Children (2011) (28)
- Pre-Travel Health Preparation of Pediatric International Travelers: Analysis From the Global TravEpiNet Consortium. (2013) (27)
- Haiti in the Context of the Current Global Cholera Pandemic (2011) (26)
- Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients (2020) (25)
- Reduction in Capsular Content and Enhanced Bacterial Susceptibility to Serum Killing of Vibrio cholerae O139 Associated with the 2002 Cholera Epidemic in Bangladesh (2005) (25)
- Evaluation of an Electricity-free, Culture-based Approach for Detecting Typhoidal Salmonella Bacteremia during Enteric Fever in a High Burden, Resource-limited Setting (2013) (24)
- O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh (2016) (24)
- Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice. (2009) (24)
- Plasma Immunoglobulin A Responses Against 2 Salmonella Typhi Antigens Identify Patients With Typhoid Fever (2018) (23)
- Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children (2016) (23)
- Conjugate Vaccines from Bacterial Antigens by Squaric Acid Chemistry: A Closer Look (2017) (23)
- Impact of DNA Extraction Method on Variation in Human and Built Environment Microbial Community and Functional Profiles Assessed by Shotgun Metagenomics Sequencing (2020) (23)
- Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers (2018) (22)
- Concomitant Enterotoxigenic Escherichia coli Infection Induces Increased Immune Responses to Vibrio cholerae O1 Antigens in Patients with Cholera in Bangladesh (2010) (22)
- Transcutaneous Immunization with a Vibrio cholerae O1 Ogawa Synthetic Hexasaccharide Conjugate following Oral Whole-Cell Cholera Vaccination Boosts Vibriocidal Responses and Induces Protective Immunity in Mice (2012) (22)
- Concurrent Pneumonia in Children Under 5 Years of Age Presenting to a Diarrheal Hospital in Dhaka, Bangladesh. (2015) (21)
- Use of Japanese Encephalitis Vaccine in US Travel Medicine Practices in Global TravEpiNet (2014) (21)
- Pre-Travel Medical Preparation of Business and Occupational Travelers (2015) (21)
- HIV Infection, Pulmonary Tuberculosis, and COPD in Rural Uganda: A Cross-Sectional Study (2018) (20)
- Non-typhoidal Salmonella gastroenteritis at a diarrheal hospital in Dhaka, Bangladesh, 1996-2011. (2013) (20)
- Optimizing the Germfree Mouse Model for In Vivo Evaluation of Oral Vibrio cholerae Vaccine and Vector Strains (2000) (20)
- Development of a new dipstick (Cholkit) for rapid detection of Vibrio cholerae O1 in acute watery diarrheal stools (2018) (20)
- Gone or forgotten? The rise and fall of Zika virus. (2018) (20)
- Analysis of the Human Mucosal Response to Cholera Reveals Sustained Activation of Innate Immune Signaling Pathways (2017) (19)
- The intestinal pathobiome: its reality and consequences among infants and young children in resource-limited settings. (2013) (19)
- Dried Blood Spots for Measuring Vibrio cholerae-specific Immune Responses (2018) (19)
- Missed Opportunities for Measles, Mumps, Rubella Vaccination Among Departing U.S. Adult Travelers Receiving Pretravel Health Consultations (2017) (19)
- Characteristics and preparation of the last-minute traveler: analysis of vaccine usage in the Global TravEpiNet Consortium (2019) (19)
- Factors associated with encephalopathy in patients with Salmonella enterica serotype Typhi bacteremia presenting to a diarrheal hospital in Dhaka, Bangladesh. (2012) (18)
- Predicting Vibrio cholerae infection and disease severity using metagenomics in a prospective cohort study (2020) (18)
- Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1 (2010) (18)
- Oral immunization with a probiotic cholera vaccine induces broad protective immunity against Vibrio cholerae colonization and disease in mice (2019) (18)
- Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh. (2012) (18)
- Antibody Avidity in Humoral Immune Responses in Bangladeshi Children and Adults following Administration of an Oral Killed Cholera Vaccine (2013) (17)
- Pre-exposure rabies vaccination among US international travelers: findings from the global TravEpiNet consortium. (2014) (16)
- Cholera: recent updates (2018) (16)
- In Vitro and In Vivo Analyses of Constitutive and In Vivo-Induced Promoters in Attenuated Vaccine and Vector Strains ofVibrio cholerae (2000) (16)
- Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh. (2022) (16)
- Plasma and Mucosal Immunoglobulin M, Immunoglobulin A, and Immunoglobulin G Responses to the Vibrio cholerae O1 Protein Immunome in Adults With Cholera in Bangladesh (2017) (15)
- Identification of In Vivo-Induced Bacterial Proteins during Human Infection with Salmonella enterica Serotype Paratyphi A (2013) (15)
- Vibriocidal Titer and Protection From Cholera in Children (2019) (15)
- Fluorescence Polarization Based Nucleic Acid Testing for Rapid and Cost-Effective Diagnosis of Infectious Disease. (2015) (15)
- Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility (2020) (14)
- Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection. (2015) (14)
- Acquisition of Antibiotic-Resistant Bacteria by U.S. International Travelers. (2020) (14)
- Familial Aggregation of Vibrio cholerae-associated Infection in Matlab, Bangladesh (2009) (13)
- Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba (2019) (12)
- Pre-Travel Preparation of US Travelers Going Abroad to Provide Humanitarian Service, Global TravEpiNet 2009–2011 (2014) (12)
- Economics of Malaria Prevention in US Travelers to West Africa (2013) (11)
- Development of a Simple, Peripheral-Blood-Based Lateral-Flow Dipstick Assay for Accurate Detection of Patients with Enteric Fever (2016) (11)
- Nanomagnetic System for Rapid Diagnosis of Acute Infection. (2017) (11)
- Malaria: epidemiology, pathogenesis, diagnosis, prevention, and treatment--an update. (2001) (11)
- Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mouse and non-human primates (2021) (10)
- Acquisition and Long-term Carriage of Multidrug-Resistant Organisms in US International Travelers (2020) (10)
- Travel Characteristics and Yellow Fever Vaccine Usage Among US Global TravEpiNet Travelers Visiting Countries with Risk of Yellow Fever Virus Transmission, 2009–2011 (2013) (10)
- Severe, Acute Watery Diarrhea in an Adult (2010) (10)
- A magneto-DNA nanoparticle system for the rapid and sensitive diagnosis of enteric fever (2016) (10)
- Troubling news from Asia about treating enteric fever: a coming storm. (2016) (9)
- Cognate T and B cell interaction and association of Follicular helper T cells with B cell responses in Vibrio cholerae O1 infected Bangladeshi adults (2018) (9)
- Evaluation of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Identification of Vibrio cholerae (2014) (9)
- Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults (2016) (9)
- Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh (2019) (9)
- The Clinical Impact and Cost-effectiveness of MMR Vaccination to Prevent Measles Importations among US International Travelers. (2018) (8)
- High depth, whole-genome sequencing of cholera isolates from Haiti and the Dominican Republic (2012) (8)
- Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults (2019) (8)
- Travel Characteristics and Pretravel Health Care Among Pregnant or Breastfeeding U.S. Women Preparing for International Travel. (2017) (8)
- Coronavirus Disease 2019 (COVID-19) Diagnostic Clinical Decision Support: A Pre-Post Implementation Study of CORAL (COvid Risk cALculator) (2021) (8)
- Characteristics of US Travelers to Zika Virus–Affected Countries in the Americas, March 2015–October 2016 (2017) (8)
- Prescribing Patterns of Antibiotics for the Self-Treatment of Travelers’ Diarrhea in Global TravEpiNet, 2009–2018 (2020) (8)
- Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae (2019) (8)
- Estimating typhoid incidence from community-based serosurveys: a multicohort study (2022) (7)
- Cholera in pregnancy: Clinical and immunological aspects. (2015) (7)
- Memory B Cell and Other Immune Responses in Children Receiving Two Doses of an Oral Killed Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh (2012) (7)
- Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infection (2022) (7)
- Comparison of Methods for Clustered Data Analysis in a Non-Ideal Situation: Results from an Evaluation of Predictors of Yellow Fever Vaccine Refusal in the Global TravEpiNet (GTEN) Consortium (2014) (7)
- Case records of the Massachusetts General Hospital. Case 20-2011. A 30-year-old man with diarrhea after a trip to the Dominican Republic. (2011) (6)
- Impact of Ramadan on clinical and microbiologic parameters of patients seen at a diarrheal hospital in urban Dhaka, Bangladesh, 1996-2012. (2014) (6)
- Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19 (2022) (6)
- Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine (2021) (6)
- Evaluation of a Screening Method for the Detection of Colistin-Resistant Enterobacteriaceae in Stool (2019) (6)
- Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera (2021) (6)
- Evaluation of a Rapid Point-of-Care Multiplex Immunochromatographic Assay for the Diagnosis of Enteric Fever (2020) (6)
- Hepatic Hydatid Cyst: A Rare Cause of Recurrent Pancreatitis (2014) (6)
- Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of Vibrio cholerae O-Specific Polysaccharide-Specific Monoclonal Antibodies (2021) (5)
- Enumeration of Gut-Homing β7-Positive, Pathogen-Specific Antibody-Secreting Cells in Whole Blood from Enterotoxigenic Escherichia coli- and Vibrio cholerae-Infected Patients, Determined Using an Enzyme-Linked Immunosorbent Spot Assay Technique (2015) (5)
- The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients (2022) (5)
- In the clinic. Travel medicine. (2012) (5)
- Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis. (2009) (5)
- Isolation, purification, characterization and direct conjugation of the lipid A-free lipopolysaccharide of Vibrio cholerae O139. (2019) (5)
- Clinical Practices for Measles-Mumps-Rubella Vaccination Among US Pediatric International Travelers. (2019) (5)
- Covishield vaccine induces robust immune responses in Bangladeshi adults (2022) (4)
- Potentially Serious Drug Interactions Resulting From the Pretravel Health Encounter (2018) (4)
- An assessment of potential biomarkers of environment enteropathy and its association with age and microbial infections among children in Bangladesh (2021) (4)
- Virus-like Particle Display of Vibrio cholerae O-Specific Polysaccharide as a Potential Vaccine against Cholera. (2022) (4)
- Eyes on the Prize: Lessons from the Cholera Wars for Modern Scientists, Physicians, and Public Health Officials† (2013) (4)
- Postgenomic approaches to cholera vaccine development (2006) (4)
- Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: a guide and case study in setting up an emergency-use, laboratory-developed molecular microbiological assay (2021) (4)
- The Gut Microbiome and Susceptibility to Vibrio cholerae Infection (2015) (4)
- Local production of anti-vibrio cholerae mucosal antibody in reproductive tract tissues after cholera. (2001) (3)
- Mucosal-Associated Invariant T (MAIT) cells are highly activated in duodenal tissue of humans with Vibrio cholerae O1 infection: A preliminary report (2022) (3)
- Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: A guide and case study in setting up an emergency-use, laboratory-developed molecular assay (2020) (3)
- Plasma Leptin Levels in Children Hospitalized with Cholera in Bangladesh (2015) (3)
- Travel associated extensively drug resistant typhoid fever: a case series to inform management in non-endemic regions. (2022) (3)
- Synthesis of glycocluster-containing conjugates for a vaccine against cholera. (2019) (3)
- The local importance of global infectious diseases (2015) (3)
- Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine (2021) (3)
- Preparing Pediatric International Travelers for Travelers' Diarrhea: Insights From the Global TravEpiNet. (2017) (3)
- The increased severity in patients presenting to hospital with diarrhea in Dhaka, Bangladesh since the emergence of the hybrid strain of Vibrio cholerae O1 is not unique to cholera patients. (2015) (3)
- The effect of transport temperature and time on the recovery of antimicrobial-resistant Enterobacterales in stool. (2020) (3)
- Identifying Recent Cholera Infections Using a Multiplex Bead Serological Assay (2022) (2)
- Clostridium difficile-Associated Diarrhea (2017) (2)
- Systemic, Mucosal, and Memory Immune Responses following Cholera (2021) (2)
- Evaluation of SARS-CoV-2 serology assays reveals a range of test performance (2020) (2)
- Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022 (2022) (2)
- Serial Profiling of SARS-CoV-2 Antigens and Antibodies in COVID-19 Patient Plasma (2020) (2)
- in whole blood in enterotoxigenic Escherichia coli and Vibrio cholerae-infected (2015) (2)
- Travel Medicine (2018) (2)
- A combination of metagenomic and cultivation approaches reveals hypermutator phenotypes within Vibrio cholerae infected patients (2020) (2)
- Systems approach to define humoral correlates of immunity to Shigella (2022) (2)
- Yellow Fever Vaccine Administration at Global TravEpiNet (GTEN) Clinics during a Period of Limited Vaccine Availability in the United States, 2017-2018. (2021) (1)
- Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of Vibrio cholerae O1 Vaccination (2022) (1)
- Transformation of the Developing World: Socioeconomic Matrix (2004) (1)
- Use and sources of medical information among departing international travelers to low and middle income countries at Logan International Airport-Boston, MA, 2009 (2010) (1)
- A Combination of Metagenomic and Cultivation Approaches Reveals Hypermutator Phenotypes within Vibrio cholerae-Infected Patients (2021) (1)
- Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139 (2021) (1)
- Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh (2022) (1)
- Erratum: Chemoproteomic profiling of host and pathogen enzymes active in cholera. (2016) (1)
- protection against infection in household contacts of cholera patients in Bangladesh (2012) (1)
- A systems serology analysis of correlates of protection against cholera (2022) (0)
- Cover Feature: Isolation, Purification, Characterization and Direct Conjugation of the Lipid A‐Free Lipopolysaccharide of Vibrio cholerae O139 (Chem. Eur. J. 56/2019) (2019) (0)
- A Co-abundant Gene Analysis for Identification of Gut Microbial Strains Associated with Immune Responses to Oral Cholera Vaccine (2021) (0)
- Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh (2022) (0)
- Enabling clinicians to easily find location-based travel health recommendations-is innovation needed? (2018) (0)
- Human B cell responses to cholera infection (2016) (0)
- Evaluation of Candida auris acquisition in U.S. international travelers using a culture-based screening protocol1. (2021) (0)
- Pretravel Assessment of Measles Immunity Status and Administration of Measles-Mumps-Rubella for Adult International Travelers Seen in Global TravEpiNet Sites (2015) (0)
- Molecular epidemiology of cryptosporidis (2000) (0)
- Identification of In Vivo-Induced Bacterial Protein Antigens during Human Infection with Salmonella enterica Serovar Typhi (2006) (0)
- TITLE : A Variant in Long Palate , Lung and Nasal Epithelium Clone 1 is Associated with Cholera in a Bangladeshi Population RUNNING TITLE : LPLUNC 1 and cholera AUTHORS : (2008) (0)
- TITLE : A combination of metagenomic and cultivation approaches reveals hypermutator 1 phenotypes within Vibrio cholerae infected patients . 2 (2021) (0)
- Single cell analyses of human antibody responses to Vibrio cholerae (2018) (0)
- Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen (2020) (0)
- Title : Vibrio cholerae genomic diversity within and between patients 1 (2017) (0)
- Demographics, medical conditions, and use of immunizations and chemoprophylaxis among international travelers within the Global TravEpiNet U.S. National Clinic Network (2010) (0)
- 622. Increased IgA Coating of Gut Microbes After Administration of Killed, Whole-Cell Oral Cholera Vaccine (2018) (0)
- Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of <italic toggle='yes'>Vibrio cholerae</italic> O-Specific Polysaccharide-Specific Monoclonal Antibodies (2021) (0)
- for accurate detection of patients with enteric fever 2 (2016) (0)
- Intrinsic Resistance to Colistin in the Genus Hafnia (2023) (0)
- Transcutaneous Vaccination with Conjugate Typhoid Vaccine Vi-DT Induces Systemic, Mucosal, and Memory Anti-Polysaccharide Responses (2020) (0)
- Induction of memory responses following transcutaneous immunization requires presence of immunoadjuvantative cholera holotoxin (53.4) (2011) (0)
- IDENTIFICATION OF SALMONELLA ENTERICA SEROVAR PARATYPHI A ANTIGENS EXPRESSED DURING CHRONIC BILIARY PARATYPHOID CARRIAGE (2015) (0)
- Defining endemic cholera at three levels of spatiotemporal resolution within Bangladesh (2018) (0)
- Vibrio cholerae Isolation from Frozen Vomitus and Stool Samples (2022) (0)
- Vaccination strategies. (2004) (0)
- Patients with Cholera in Bangladesh Infection from Household Contacts of Associated with Protection against cholerae O1 Lipopolysaccharide Are Memory B Cell Responses to Vibrio (2012) (0)
- Development of a prediction model for the Acquisition of Extended Spectrum Beta-Lactam Resistant Organisms in U.S. international travellers. (2023) (0)
- Corrigendum: Isolation, Purification, Characterization and Direct Conjugation of the Lipid A-Free Lipopolysaccharide of Vibrio cholerae O139. (2020) (0)
- Distinguishing SARS-CoV-2 persistence and reinfection: A retrospective cohort study. (2022) (0)
- Travel Medicine (2012) (0)
- 738. Comparison of Characteristics of US International Travelers Seeking Pretravel Health Consultations at US Global TravEpiNet Sites Before and During the COVID-19 Pandemic (2021) (0)
- Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study (2022) (0)
- RISK FACTORS FOR DEATH FROM CHOLERA (1998) (0)
- Estimating the incidence of typhoidal Salmonella from cross-sectional serology using antibody dynamics following infection (2021) (0)
- 180. Alterations to the Gut Microbiomes and Acquisition of Bacteria Resistance Elements among US International Travelers (2021) (0)
- High-risk US International Travelers Seeking Pretravel Consultation During the COVID-19 Pandemic (2022) (0)
- Chapter 45 – Cholera (2009) (0)
- Correction: Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh (2021) (0)
- The Clinical and Economic Impact of Measles-Mumps-Rubella Vaccinations to Prevent Measles Importations From US Pediatric Travelers Returning From Abroad (2022) (0)
- Predicting Vibrio cholerae infection and symptomatic disease: a systems serology study. (2023) (0)
- The determination of the partition coefficients for a variety of pyrrolizidine alkaloids and the relationship of these values to the anti-tumor activity of the alkaloids (1988) (0)
- Cholera: Updates in Global Situation and Control Strategies (2016) (0)
- 1105. Vibriocidal Titer Variation and Likelihood of Protection in Children Compared With Adults in a Cholera Endemic Area (2018) (0)
- Medical Considerations before International Travel. (2016) (0)
- Assessing antigen specific HLA-DR+ antibody secreting cell (DR+ASC) responses in whole blood in enteric infections using an ELISPOT technique. (2017) (0)
- 2769. The Clinical and Economic Impact of MMR Vaccinations to Prevent Measles Importations from US Pediatric Travelers Returning from Abroad (2019) (0)
- Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19 (2022) (0)
- Erratum to: Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of Vibrio cholerae O1 Vaccination (2022) (0)
- High depth, whole-genome sequencing of cholera isolates from Haiti and the Dominican Republic (2012) (0)
- Title: A comparison of memory B cell, antibody secreting cell, and plasma antibody responses in (2011) (0)
- 772Risk Factors Associated with Pneumonia Co-infection in Children under 5 Years of Age Presenting to a Diarrheal Hospital in Dhaka, Bangladesh, 1996 to 2007 (2014) (0)
This paper list is powered by the following services:
Other Resources About Edward Thomas Ryan
What Schools Are Affiliated With Edward Thomas Ryan?
Edward Thomas Ryan is affiliated with the following schools:
